SYNWEAVE

Live / Applied — Statement of use — registration review complete (as of 07 Oct 2026)

What this means for you

Not registered yet, but its 05 Jul 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
98634064
Mark type
Word mark
Filed
05 Jul 2024
Published for opposition
28 Oct 2025
Attorney of record
Lauren K. Tagarao

Goods and services

  • Class 040 — Treatment of materials: Contract manufacturing and custom manufacture for biopharmaceutical companies for process development of manufacturing process of biologics being industrial chemicals in the fields of cell line development, clone selection, analytical methods, formulation, scale-up of the manufacturing process, manufacture of drug substance and drug product, viral testing, and viral clearance studies
  • Class 042 — Scientific and technological services: Scientific research and development for biopharmaceutical companies in the field of biologics being antibodies, proteins, cells, and nucleic acids; custom design and development of chemical regents and biochemical assays being biochemicals and biopharmaceuticals; laboratory testing of materials; laboratory testing of materials services; testing of pharmaceuticals; biochemical engineering; biopharmaceutical drug development services being pharmaceutical drug development services; biopharmaceutical products development being research and development of new products; biopharmaceutical substance and products manufacturing being research and development of new products; development of pharmaceutical preparations and medicines; scientific study and research in the fields of reproduction, husbandry, and general health of animal; biotechnology research being scientific research for determining the neuronal survival of molecules in animal models; scientific research and development services in the fields of proteins, antibodies, antibody technology; custom design and development of biochemical reagents being chemical reagents and biochemical assays; design, engineering, research, development and testing services of new products for others in the fields of biochemicals, materials customization for medical, scientific, and technological applications; viral testing services being product quality testing services; viral testing analysis being chemical analysis; toxicity testing for research purposes being chemical analysis; conducting and providing tests being chemical analysis and supporting analysis for clinical trials being chemical analysis; providing medical and scientific research information in the field of clinical trials; conducting early evaluations in the field of new pharmaceuticals; scientific research being analytical services for scientific research purposes; laboratory research in the field of chemistry being protein expression; scientific research services relating to the isolation and cultivation of human tissues and cells; scientific research being preparation of reports relating to scientific and technical research; scientific research being analysis in the field of molecular biology; scientific research being contract research services relating to molecular sciences; biological cloning services; structural and functional analysis of genomes; scientific laboratory services; services of a chemical and biological laboratory being scientific laboratory services; laboratory research services relating to pharmaceuticals; scientific research and development and scientific research consultation in the fields of antibodies, antibody technology, chemistry, bioinformatics, biomedical, biologics, biotechnology, biotherapeutics, biology, biochemical, cell line, chemoinformatic, genetics and genetic engineering, gene expression systems, in vitro, inhalation pharmaceuticals, molecular sciences, micro-organisms, nutrition, and ophthalmic; scientific and technological services, namely, scientific research, scientific development, analysis, testing, engineering, extraction being scientific development, synthesis being scientific development, purification being scientific development, and production being scientific development in the fields of antibody, application programming interfaces, biomolecules, cell bank characterization, chiral, chromosome aberration, clinical chemistry, cloning vector, DNA, flow cytometry, mass spectrometry, gene, immuno-pharmaceuticals, in vitro assays, large molecule, liquid chromatography mass spectrometry, microbial, monomer, nanoparticle, natural products, peptides, proteins, RNA, supercritical fluid chromatography, and vaccines

Owner

Prosecution history

  • 07 Oct 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
  • 07 Oct 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
  • 11 Aug 2026 — STATEMENT OF USE PROCESSING COMPLETE
  • 18 Jun 2026 — USE AMENDMENT FILED
  • 18 Jun 2026 — TEAS STATEMENT OF USE RECEIVED
  • 23 Dec 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
  • 28 Oct 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 28 Oct 2025 — PUBLISHED FOR OPPOSITION
  • 22 Oct 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
  • 30 Sept 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
  • 24 Sept 2025 — EXAMINER'S AMENDMENT ENTERED
  • 24 Sept 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
  • 24 Sept 2025 — EXAMINERS AMENDMENT E-MAILED
  • 24 Sept 2025 — EXAMINERS AMENDMENT -WRITTEN
  • 14 May 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED

View this trademark record on Rightsy